CSIMarket
 


Zai Lab Limited  (ZLAB)
Other Ticker:  
 
 

ZLAB's Net Cash Flow Growth by Quarter and Year

Zai Lab Limited's Net Cash Flow results by quarter and year




ZLAB Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.67 -111.01 -434.34 13.49
III Quarter September -70.35 438.66 -368.08 0.00
II Quarter June -19.90 -166.14 753.15 0.00
I Quarter March -128.43 -117.14 571.30 0.00
FY   -218.01 44.37 522.03 13.49



ZLAB Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Zai Lab Limited in the fourth quarter 2023 achieved Net Cash Flow of $ 0.67 millions compare to net cash outflow recorded in same quarter a year ago.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Net Cash Flow growth. While Zai Lab Limited' s Net Cash Flow no change of % ranks overall at the positon no. 224 in the fourth quarter 2023.




ZLAB Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - -91.5 % 3769.76 % -

Financial Statements
Zai Lab Limited's fourth quarter 2023 Net Cash Flow $ 0.67 millions ZLAB's Income Statement
Zai Lab Limited's fourth quarter 2022 Net Cash Flow $ -111.01 millions Quarterly ZLAB's Income Statement
New: More ZLAB's historic Net Cash Flow Growth >>


ZLAB Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - 31.83 % -
I Quarter March - - 4134.99 % -
FY (Year on Year)   - -91.5 % 3769.76 % -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #18
Overall #224

Net Cash Flow Y/Y Growth Statistics
High Average Low
-91.5 % -270.54 % -591.34 %
(Dec 31 2022)   (Dec 31 2023)
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #18
Overall #224
Net Cash Flow Y/Y Growth Statistics
High Average Low
-91.5 % -270.54 % -591.34 %
(Dec 31 2022)   (Dec 31 2023)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Zai Lab Limited's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ZLAB's IV. Quarter Q/Q Net Cash Flow Comment
This turnaround IV. Quarter 2023where Zai Lab Limited delivered Net Cash Flow of $ 0.67 millions should be inception of improved results.Zai Lab Limited announced in the IV. Quarter 2023 Net Cash Flow of $ 0.67 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Zai Lab Limited achieved highest sequential Net Cash Flow growth. While Zai Lab Limited's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ZLAB's IV. Quarter Q/Q Net Cash Flow Comment
Improvement IV. Quarter 2023where Zai Lab Limited delivered Net Cash Flow of $ 0.67 millions should be inception of positive performance.Zai Lab Limited announced in the IV. Quarter 2023 Net Cash Flow of $ 0.67 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Zai Lab Limited achieved highest sequential Net Cash Flow growth. While Zai Lab Limited's Net Cash Flow growth quarter on quarter, overall rank is .


Zai Lab Limited's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -218.01 $ -329.68 $ 179.32 $ 33.09 $ 44.37
Y / Y Net Cash Flow Growth (TTM) - - - - -91.5 %
Year on Year Net Cash Flow Growth Overall Ranking # 303 # 290 # 483 # 550 # 356
Seqeuential Net Cash Flow Change (TTM) - - 441.97 % -25.43 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 224 # 216 # 334 # 365 # 274




Cumulative Net Cash Flow growth Comment
Zai Lab Limited realized trailing twelve months net cash outflow of $ -218 millions, in the Dec 31 2023, compare to Net Cash Flow of $ 44 millions a year ago.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 290 to 303.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-91.5 %
-270.54 %
-591.34 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 28
Overall # 303

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
-91.5 %
-270.54 %
-591.34 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 18
S&P 500 # 224
Cumulative Net Cash Flow growth Comment
Zai Lab Limited realized trailing twelve months net cash outflow of $ -218 millions, in the Dec 31 2023, compare to Net Cash Flow of $ 44 millions a year ago.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 290 to 303.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-91.5 %
-270.54 %
-591.34 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 28
Overall # 303

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
-91.5 %
-270.54 %
-591.34 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 18
S&P 500 # 224




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
ZLAB's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for ZLAB's Competitors
Net Cash Flow Growth for Zai Lab Limited's Suppliers
Net Cash Flow Growth for ZLAB's Customers

You may also want to know
ZLAB's Annual Growth Rates ZLAB's Profitability Ratios ZLAB's Asset Turnover Ratio ZLAB's Dividend Growth
ZLAB's Roe ZLAB's Valuation Ratios ZLAB's Financial Strength Ratios ZLAB's Dividend Payout Ratio
ZLAB's Roa ZLAB's Inventory Turnover Ratio ZLAB's Growth Rates ZLAB's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com